In the process of characterizing the Naf-binding properties of factor Xa, a
specific inhibition of this enzyme by quaternary amines was identified, co
nsistent with previous observations. The binding occurs with K-i in the low
millimolar range, with trimethylphenylammonium (TMPA) showing the highest
specificity. Binding of TMPA inhibits substrate hydrolysis in a competitive
manner, does not inhibit the binding of p-aminobenzamidine to the S1 pocke
t, and is positively linked to Na+ binding. Inhibition by TMPA is also seen
in thrombin and tissue plasminogen activator (tPA), though to a lesser ext
ent compared to factor Xa. Computer modeling using the crystal structure of
factor Xa suggests that TMPA binds to the S2/S3 specificity sites, with it
s hydrophobic moiety making van der Waals interactions with the side chains
of Y99, F174, and W215, and the charged amine coupling electrostatically w
ith the carboxylates of E97. Site-directed mutagenesis of factor Xa, thromb
in, and tPA confirms the predictions drawn by docking calculations and reve
al a dominant role for residue Y99. Binding of TMPA to factor Xa is drastic
ally (25-fold) reduced by the Y99T replacement. Likewise, the Y99L substitu
tion compromises binding of TMPA to tPA. On the other hand, the affinity of
TMPA is enhanced 4-fold in thrombin with the substitution L99Y. The identi
fication of a binding site for quaternary amines in factor Xa has a bearing
on the rational design of selective inhibitors of this clotting enzyme.